CYBX Insider Trading
CYBX | Market Equity
Comprehensive Trading Performance Summary
The investment history of corporate insiders at CYBX provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Market Equity sector.
Transactions on Chart
Open Full Chart| Filing Date | Trade Date | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|
| 2007-03-03 01:29 | 2007-02-28 | COELHO TONY | Other | OPT+S | $16.00 | 34,100 | $545,573 | 72,232 | 0.0% |
| 2006-07-26 23:16 | 2006-07-24 | RUDOLPH RICHARD | Officer - VP, Clinical & Medical Affairs | SELL | $20.36 | 11,933 | $242,909 | 10,000 | -54.4% |
| 2006-06-12 23:58 | 2006-06-09 | TERRY REESE S JR | Director | SELL | $22.83 | 8,500 | $194,082 | 380,430 | -2.2% |
| 2006-06-07 23:18 | 2006-06-06 | LUNNEY SHAWN P | Officer - VP, Mkt Development | OPT+S | $24.00 | 15,000 | $360,000 | 32,472 | 0.0% |
| 2006-06-03 00:16 | 2006-06-01 | SIMPSON RANDAL L | Officer - Vice President, Operations | SELL | $25.00 | 2,000 | $50,000 | 8,808 | -18.5% |
| 2006-06-02 23:13 | 2006-06-01 | JENNINGS WILLIAM STEVEN | Officer - Vice President, Sales | OPT+S | $25.17 | 21,000 | $528,511 | 4,000 | 0.0% |
| 2006-06-03 00:13 | 2006-06-01 | RUDOLPH RICHARD | Officer - VP, Clinical & Medical Affairs | SELL | $24.62 | 2,500 | $61,551 | 21,933 | -10.2% |
| 2006-06-03 00:09 | 2006-06-01 | CHENEY MICHAEL A | Officer - Vice President, Marketing | SELL | $24.38 | 1,000 | $24,384 | 4,150 | -19.4% |
| 2006-03-18 00:07 | 2006-03-16 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | OPT+S | $26.64 | 18,000 | $479,596 | 9,773 | 0.0% |
| 2006-03-17 00:39 | 2006-03-14 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | OPT+S | $26.11 | 16,684 | $435,591 | 9,773 | 0.0% |
| 2006-02-14 22:58 | 2005-03-29 | BOSTON SCIENTIFIC CORP | 10% owner | BUY | $40.23 | 134,860 | $5,425,472 | 3,570,000 | +3.9% |
| 2006-01-07 01:21 | 2006-01-02 | OLSEN ALAN J | Director | OPT+S | $31.22 | 19,000 | $593,087 | 8,475 | 0.0% |
| 2005-12-24 00:02 | 2005-12-22 | LUNNEY SHAWN P | Officer - VP, Mkt Development | OPT+S | $32.83 | 10,000 | $328,260 | 32,472 | 0.0% |
| 2005-12-15 19:34 | 2005-12-13 | MOORE KEVIN S | Director | BUY | $29.66 | 6,800 | $201,712 | 823,133 | +0.8% |
| 2005-12-15 19:30 | 2005-12-13 | MOORE KEVIN S | Director | BUY | $29.36 | 38,100 | $1,118,681 | 816,333 | +4.9% |
| 2005-12-14 00:04 | 2005-12-12 | MOORE KEVIN S | Director | BUY | $29.70 | 55,100 | $1,636,415 | 778,233 | +7.6% |
| 2005-10-12 22:31 | 2005-10-12 | JACKSON GUY C | Director | BUY | $27.51 | 1,000 | $27,509 | 7,500 | +15.4% |
| 2005-10-12 20:17 | 2005-10-11 | COELHO TONY | Director | BUY | $28.73 | 3,400 | $97,697 | 12,500 | +37.4% |
| 2005-10-12 19:43 | 2005-10-12 | CUMMINS ROBERT P | Officer - Chief Exec Officer, Chairman | BUY | $27.90 | 5,000 | $139,500 | 153,750 | +3.4% |
| 2005-10-11 18:49 | 2005-10-07 | WESTBROOK PAMELA B | Officer - Chief Financial Officer | BUY | $28.20 | 1,100 | $31,020 | 13,409 | +8.9% |
| 2005-10-11 19:09 | 2005-10-05 | CUMMINS ROBERT P | Officer - Chief Exec Officer, Chairman | BUY | $28.93 | 12,500 | $361,624 | 148,750 | +9.2% |
| 2005-04-09 00:26 | 2005-04-07 | SIMPSON RANDAL L | Officer - Vice President, Operations | OPT+S | $45.00 | 10,000 | $450,000 | 808 | 0.0% |
| 2005-04-09 00:18 | 2005-04-07 | PARKER GEORGE E | Officer - VP, Human Resources | OPT+S | $45.00 | 10,000 | $450,000 | 100 | 0.0% |
| 2005-03-31 22:22 | 2005-03-29 | BOSTON SCIENTIFIC CORP | 10% owner | BUY | $39.83 | 75,140 | $2,992,856 | 3,435,140 | +2.2% |
| 2005-03-31 00:55 | 2005-03-28 | BOSTON SCIENTIFIC CORP | 10% owner | BUY | $38.97 | 60,000 | $2,338,230 | 3,360,000 | +1.8% |
| 2005-02-22 20:43 | 2005-02-15 | ADVANCED NEUROMODULATION SYSTEMS INC | 10% owner | SELL | $39.08 | 510,000 | $19,932,942 | 2,643,000 | -16.2% |
| 2005-02-22 23:08 | 2005-02-18 | CHENEY MICHAEL A | Officer - Vice President, Marketing | OPT+S | $40.11 | 11,753 | $471,373 | 150 | 0.0% |
| 2005-02-19 03:36 | 2005-02-17 | ADVANCED NEUROMODULATION SYSTEMS INC | 10% owner | SELL | $38.64 | 1,083,000 | $41,845,387 | 0 | -100.0% |
| 2005-02-19 03:35 | 2005-02-16 | ADVANCED NEUROMODULATION SYSTEMS INC | 10% owner | SELL | $38.18 | 1,560,000 | $59,558,772 | 1,083,000 | -59.0% |
| 2005-02-19 00:25 | 2005-02-17 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | OPT+S | $39.95 | 19,050 | $761,084 | 0 | 0.0% |
| 2005-02-17 19:59 | 2005-02-15 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | OPT+S | $41.00 | 950 | $38,950 | 0 | 0.0% |
| 2005-02-17 03:12 | 2005-02-14 | ADVANCED NEUROMODULATION SYSTEMS INC | 10% owner | SELL | $39.71 | 857,000 | $34,028,128 | 2,643,000 | -24.5% |
| 2005-02-16 22:26 | 2005-02-10 | SIMPSON RANDAL L | Officer - Vice President, Operations | OPT+S | $40.75 | 20,000 | $815,004 | 149,500 | 0.0% |
| 2005-02-16 22:46 | 2005-02-10 | SIMPSON RANDAL L | Officer - Vice President, Operations | OPT+S | $40.75 | 20,000 | $815,004 | 808 | 0.0% |
| 2005-02-16 22:19 | 2005-02-14 | CHENEY MICHAEL A | Officer - Sr. VP, Marketing & Sales | BUY | $41.25 | 300 | $12,375 | 150 | +100.0% |
| 2005-02-16 22:19 | 2005-02-14 | CHENEY MICHAEL A | Officer - Sr. VP, Marketing & Sales | OPT+S | $41.13 | 22,947 | $943,877 | 450 | 0.0% |
| 2005-02-16 22:23 | 2005-02-14 | COELHO TONY | Director | SELL | $40.57 | 5,700 | $231,232 | 4,100 | -58.2% |
| 2005-02-14 23:03 | 2005-02-10 | TERRY REESE S JR | Director | SELL | $42.82 | 25,000 | $1,070,408 | 350,430 | -6.7% |
| 2005-02-14 21:00 | 2005-02-10 | JENNINGS WILLIAM STEVEN | Officer - Vice President, Sales | OPT+S | $41.26 | 20,000 | $825,118 | 0 | 0.0% |
| 2005-02-14 20:55 | 2005-02-10 | APPEL STANLEY H MD | Director | OPT+S | $39.42 | 20,000 | $788,424 | 63,800 | 0.0% |
| 2005-02-14 21:04 | 2005-02-10 | WESTBROOK PAMELA B | Officer - Chief Financial Officer | OPT+S | $42.57 | 30,000 | $1,277,016 | 7,309 | 0.0% |
| 2005-02-14 20:57 | 2005-02-10 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | OPT+S | $42.19 | 43,010 | $1,814,579 | 0 | 0.0% |
| 2005-02-15 00:01 | 2005-02-10 | CHENEY MICHAEL A | Officer - Sr. VP, Marketing & Sales | SELL | $42.38 | 1,461 | $61,918 | 150 | -90.7% |
| 2005-02-14 21:38 | 2005-02-10 | LUNNEY SHAWN P | Officer - VP, Mkt Development | SELL | $43.55 | 7,800 | $339,724 | 22,472 | -25.8% |
| 2005-02-14 22:15 | 2005-02-10 | LUNNEY SHAWN P | Officer - VP, Mkt Development | SELL | $43.55 | 7,500 | $326,651 | 22,472 | -25.0% |
| 2005-02-14 20:48 | 2005-02-10 | CUMMINS ROBERT P | Officer - Chief Exec Officer, Chairman | SELL | $44.24 | 50,200 | $2,221,094 | 36,250 | -58.1% |
| 2005-02-14 20:43 | 2005-02-10 | CUMMINS ROBERT P | Officer - Chief Exec Officer, Chairman | SELL | $43.08 | 119,351 | $5,141,402 | 86,450 | -58.0% |
| 2005-02-14 20:41 | 2005-02-10 | CUMMINS ROBERT P | Officer - Chief Exec Officer, Chairman | OPT+S | $40.67 | 180,449 | $7,338,698 | 205,801 | 0.0% |
| 2004-09-16 17:53 | 2004-09-14 | TERRY REESE S JR | Director | OPT+S | $18.35 | 4,500 | $82,590 | 375,430 | 0.0% |
| 2004-09-17 00:48 | 2004-09-16 | TOTAH ALAN D | Officer - VP, Regulatory Affairs,Quality | SELL | $22.58 | 1,000 | $22,585 | 0 | -100.0% |
How to Interpret $CYBX Trades
Not every insider transaction in CYBX is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $CYBX shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.
Data Source & Accuracy for CYBX
Insider activity data for CYBX is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $CYBX, allowing you to follow the capital of those with the most intimate knowledge of the company.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.